Рет қаралды 1,429
WPLG Local 10
Dr. Jose Lutzky with Sylvester Comprehensive Cancer Center at the University of Miami Health System said a new immunotherapy drug combo of Nivolumab and Relatlimab targets tumors with less toxicity to the patient.